Lazard Asset Management
TELA icon

Lazard Asset Management’s TELA Bio TELA Stock Holding History

Lazard Asset Management’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,116
Closed -$4K – 2300
2025
Q2 		$4K Buy
+2,116
New +$2.77K ﹤0.01% 2206

Other funds holding TELA

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Lazard Asset Management's TELA Position: Q3 2025 in Review

Lazard Asset Management sold out of TELA Bio (TELA) in Q3 2025, closing a stake of 2,116 shares — an estimated $4K sold.

Lazard Asset Management first reported a position in TELA in Q2 2025 and held it in 1 quarter. The position peaked at $4K in Q2 2025. 40 funds tracked by Wall St. Rank hold TELA as of Q3 2025.

  • Lazard Asset Management reported no remaining TELA Bio position as of Q3 2025 after selling out during the quarter.
  • Lazard Asset Management sold 2,116 TELA Bio shares in Q3 2025, an estimated $4K.
  • Lazard Asset Management first reported a position in TELA Bio in Q2 2025 and held it in 1 quarter.
  • Lazard Asset Management's TELA Bio position peaked at $4K in Q2 2025.
  • 40 funds tracked by Wall St. Rank held TELA Bio as of Q3 2025.

Based on Lazard Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.